BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1203 related articles for article (PubMed ID: 33284825)

  • 1. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
    Shin EK; Choi HY; Hayes N
    Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.
    Ozturk S; Turgutalp K; Arici M; Odabas AR; Altiparmak MR; Aydin Z; Cebeci E; Basturk T; Soypacaci Z; Sahin G; Elif Ozler T; Kara E; Dheir H; Eren N; Suleymanlar G; Islam M; Ogutmen MB; Sengul E; Ayar Y; Dolarslan ME; Bakirdogen S; Safak S; Gungor O; Sahin I; Mentese IB; Merhametsiz O; Oguz EG; Genek DG; Alpay N; Aktas N; Duranay M; Alagoz S; Colak H; Adibelli Z; Pembegul I; Hur E; Azak A; Taymez DG; Tatar E; Kazancioglu R; Oruc A; Yuksel E; Onan E; Turkmen K; Hasbal NB; Gurel A; Yelken B; Sahutoglu T; Gok M; Seyahi N; Sevinc M; Ozkurt S; Sipahi S; Bek SG; Bora F; Demirelli B; Oto OA; Altunoren O; Tuglular SZ; Demir ME; Ayli MD; Huddam B; Tanrisev M; Bozaci I; Gursu M; Bakar B; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Ates K
    Nephrol Dial Transplant; 2020 Dec; 35(12):2083-2095. PubMed ID: 33275763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
    Bajgain KT; Badal S; Bajgain BB; Santana MJ
    Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
    PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
    Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis.
    Noor FM; Islam MM
    J Community Health; 2020 Dec; 45(6):1270-1282. PubMed ID: 32918645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019.
    Rosenthal JA; Awan SF; Fintzi J; Keswani A; Ein D
    Ann Allergy Asthma Immunol; 2021 Jan; 126(1):93-95. PubMed ID: 33059035
    [No Abstract]   [Full Text] [Related]  

  • 14. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
    Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
    Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.
    Alguwaihes AM; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alzahrani SH; Sabico S; Al-Daghri NM; Jammah AA
    Cardiovasc Diabetol; 2020 Dec; 19(1):205. PubMed ID: 33278893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.
    Mithal A; Jevalikar G; Sharma R; Singh A; Farooqui KJ; Mahendru S; Krishnamurthy A; Dewan A; Budhiraja S
    Diabetes Metab Syndr; 2021; 15(1):169-175. PubMed ID: 33360081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico.
    Parra-Bracamonte GM; Lopez-Villalobos N; Parra-Bracamonte FE
    Ann Epidemiol; 2020 Dec; 52():93-98.e2. PubMed ID: 32798701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between chronic kidney disease and COVID-19-related mortality in New York.
    Mohamed NE; Benn EKT; Astha V; Okhawere KE; Korn TG; Nkemdirim W; Rambhia A; Ige OA; Funchess H; Mihalopoulos M; Meilika KN; Kyprianou N; Badani KK
    World J Urol; 2021 Aug; 39(8):2987-2993. PubMed ID: 33481113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.